Abstract
It is widely argued that patents block entry of generic drugs and thus patent system has negative impact on growth of pharma industry in developing countries and survival of industry is possible as long as weaker protection for patents subsists. However, countries having effective patent regime have proved and achieved R & D to sales ratio apart from profitability ratio,as a result, no longer depend solely on copycat manufacturing. The paper examines economic growth rate of emerging countries, having strong patent regime and seeks to find out the legislative mechanism and measures adopted by them in wake of TRIPs and related developments to attain R & D to sales ratio.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
